202 related articles for article (PubMed ID: 20947473)
1. Tumor markers as a diagnostic key for hilar cholangiocarcinoma.
Juntermanns B; Radunz S; Heuer M; Hertel S; Reis H; Neuhaus JP; Vernadakis S; Trarbach T; Paul A; Kaiser GM
Eur J Med Res; 2010 Aug; 15(8):357-61. PubMed ID: 20947473
[TBL] [Abstract][Full Text] [Related]
2. [The value of CA19-9 and CEA in predicting resectability of hilar cholangiocarcinoma].
Zong D; Zeng Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 45(5):819-22. PubMed ID: 25341348
[TBL] [Abstract][Full Text] [Related]
3. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
[TBL] [Abstract][Full Text] [Related]
4. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA.
Qin XL; Wang ZR; Shi JS; Lu M; Wang L; He QR
World J Gastroenterol; 2004 Feb; 10(3):427-32. PubMed ID: 14760772
[TBL] [Abstract][Full Text] [Related]
5. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
[TBL] [Abstract][Full Text] [Related]
6. Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.
Leelawat K; Sakchinabut S; Narong S; Wannaprasert J
BMC Gastroenterol; 2009 Apr; 9():30. PubMed ID: 19405942
[TBL] [Abstract][Full Text] [Related]
7. CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation.
Fisher A; Theise ND; Min A; Mor E; Emre S; Pearl A; Schwartz ME; Miller CM; Sheiner PA
Liver Transpl Surg; 1995 Mar; 1(2):94-8. PubMed ID: 9346547
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma.
Cai WK; Lin JJ; He GH; Wang H; Lu JH; Yang GS
Int J Clin Exp Pathol; 2014; 7(11):7890-8. PubMed ID: 25550829
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between clinicopathological features and CA19-9/CEA in patients with extrahepatic cholangiocarcinoma].
Tang X; Zhang J; Chen Y; Lan Z; Wang C
Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):662-6. PubMed ID: 25564055
[TBL] [Abstract][Full Text] [Related]
10. [CA19-9 in intrahepatic cholangiocarcinoma : A diagnostic and prognostic armamentarium?].
Juntermanns B; Kaiser GM; Itani Gutierrez S; Heuer M; Buechter M; Kahraman A; Reis H; Kasper S; Paul A; Fingas CD
Chirurg; 2018 Jun; 89(6):466-471. PubMed ID: 29644426
[TBL] [Abstract][Full Text] [Related]
11. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma.
Fang T; Wang H; Wang Y; Lin X; Cui Y; Wang Z
Dis Markers; 2019; 2019():6016931. PubMed ID: 30863466
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen, α-fetoprotein, and Ki67 as biomarkers and prognostic factors in intrahepatic cholangiocarcinoma: A retrospective cohort study.
Qiang Z; Zhang W; Jin S; Dai K; He Y; Tao L; Yu H
Ann Hepatol; 2021; 20():100242. PubMed ID: 32841741
[TBL] [Abstract][Full Text] [Related]
14. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions.
Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H
Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676
[TBL] [Abstract][Full Text] [Related]
15. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
[TBL] [Abstract][Full Text] [Related]
16. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.
Hultcrantz R; Olsson R; Danielsson A; Järnerot G; Lööf L; Ryden BO; Wahren B; Broomé U
J Hepatol; 1999 Apr; 30(4):669-73. PubMed ID: 10207809
[TBL] [Abstract][Full Text] [Related]
17. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
[TBL] [Abstract][Full Text] [Related]
18. The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma.
Singh S; Tang SJ; Sreenarasimhaiah J; Lara LF; Siddiqui A
Dig Dis Sci; 2011 Aug; 56(8):2491-6. PubMed ID: 21516323
[TBL] [Abstract][Full Text] [Related]
19. CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma.
Loosen SH; Roderburg C; Kauertz KL; Koch A; Vucur M; Schneider AT; Binnebösel M; Ulmer TF; Lurje G; Schoening W; Tacke F; Trautwein C; Longerich T; Dejong CH; Neumann UP; Luedde T
Sci Rep; 2017 Dec; 7(1):16975. PubMed ID: 29208940
[TBL] [Abstract][Full Text] [Related]
20. Double-Negative α-Fetoprotein and Carbohydrate Antigen 19-9 Predict a Good Prognosis in Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis.
Zhang X; Zhou Y; Wu Z; Peng W; Li C; Yan L; Yang J; Wen T
Clin Transl Gastroenterol; 2021 Nov; 12(11):e00425. PubMed ID: 34751187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]